Angela DeMichele, MD, MSCE

Angela DeMichele, MD, MSCE

Alan and Jill Miller Professor in Breast Cancer Excellence
  • Alan and Jill Miller Professor in Breast Cancer Excellence

  • University of Pennsylvania Perelman School of Medicine
  • Co-Leader, Breast Cancer Research Program
  • Co-Director, 2-PREVENT Breast Cancer Translational Center of Excellence

Dr. DeMichele’s research focuses on preventing breast cancer recurrence and metastasis with targeted drug combinations to eliminate disseminated tumor cells.  Since 2005, she has been the Co-Leader of the Breast Cancer Research Program in the Abramson Cancer Center, where she also directs both the Breast Cancer Clinical Research Unit and the Breast Cancer TRACR Biobank.  Dr. DeMichele has authored over 130 publications in high-impact journals such as NEJM and JAMA and has been funded by the NIH, NCI, DOD and Stand Up to Cancer.  She was recently awarded the 2023 Gianni Bonadonna Breast Cancer Award from ASCO and The Conquer Cancer Foundation.


Content Area Specialties

  • Adjuvant Chemotherapy
  • Aromatase Inhibitor
  • Atypical Ductal Hyperplasia
  • BRCA Gene Mutation (BRCA 1 and BRCA 2)
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer During Pregnancy
  • Breast Cancer Follow Up
  • Breast Cancer Genetics
  • Breast Cancer High-Risk Counseling
  • Breast Cancer Immunotherapy
  • Cancer Immunotherapy
  • Carcinoma In Situ of Breast
  • Clinical Trials
  • Cystosarcoma Phyllodes
  • Ductal Carcinoma in Situ (DCIS)
  • ER Negative Breast Cancer
  • ER Positive Breast Cancer
  • Family History of Breast Cancer
  • Herceptin
  • Hereditary Breast and Ovarian Cancer
  • Inflammatory Breast Cancer (IBC)
  • Invasive Breast Cancer
  • Lobular Carcinoma in Situ (LCIS)
  • Lobular Neoplasia
  • Male Breast Cancer
  • Neoadjuvant Chemotherapy
  • Sentinel Lymph Node Biopsy
  • Tamoxifen
  • Triple-Negative Breast Cancer